H.R.3912 - Chronic Kidney Disease Improvement in Research and Treatment Act116th Congress (2019-2020)
|Sponsor:||Rep. Lewis, John [D-GA-5] (Introduced 07/23/2019)|
|Committees:||House - Energy and Commerce; Ways and Means|
|Latest Action:||House - 07/24/2019 Referred to the Subcommittee on Health. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.3912 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in House (07/23/2019)
Chronic Kidney Disease Improvement in Research and Treatment Act
This bill expands, establishes, and otherwise modifies requirements under Medicare and other health care programs relating to individuals with end-stage renal disease (ESRD).
Among other things, the bill
- expands the scope of the National Health Service Corps to specifically include kidney disease specialists,
- modifies payments under the Medicare ESRD program to exclude certain adjustment factors (e.g., comorbidities),
- authorizes incentive payments for renal dialysis facilities that exceed performance standards under the Medicare ESRD program, and
- expands guaranteed issue rights with respect to Medigap policies (Medicare supplemental health insurance policies) to all ESRD beneficiaries.